CN203291375U - Visualized tract drug delivery device - Google Patents
Visualized tract drug delivery device Download PDFInfo
- Publication number
- CN203291375U CN203291375U CN2013203632466U CN201320363246U CN203291375U CN 203291375 U CN203291375 U CN 203291375U CN 2013203632466 U CN2013203632466 U CN 2013203632466U CN 201320363246 U CN201320363246 U CN 201320363246U CN 203291375 U CN203291375 U CN 203291375U
- Authority
- CN
- China
- Prior art keywords
- topical
- visual
- drug delivery
- drug administration
- tract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn - After Issue
Links
Images
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The utility model relates to a novel clinical medical instrument, in particular to a visualized tract drug delivery device which comprises a local drug delivery atomizer, a visible device and a transparent pipe made of medical polymer materials. A local drug delivery channel and an observation tract are axially arranged in the pipe. The local drug delivery atomizer is connected with a connector arranged at the back end of the pipe, drugs are delivered to the local drug delivery channel through the connector, and optical fibers are arranged in the observation tract and are led to the outer side of the pipe from the observation tract to form a leading-out end connected with a signal input end of the visible device. The visualized tract drug delivery device is efficient in use and can accurately deliver drugs to tract nidus portions.
Description
Technical field
It is efficient that this utility model relates to a kind of clinical medical apparatus and instruments of using, particularly a kind of use, accurately visual doser in local tract.
Background technology
The treatment of pulmonary infection is to give antimicrobial drug by oral or vein.Medicine arrives lesions position by blood circulation, reaches therapeutic purposes.Although intravenously administrable can make pulmonary parenchyma reach effective antibacterials concentration level, be penetrated into tube chamber limited with the endocrine medicine of pipe.Especially multi-drug resistant bacteria is insensitive to common antibiotics, and the routine dose intravenous administration is difficult to reach the active drug concentration for the treatment of in focus of infection, and causes therapeutic effect poor.Although and sensitive antibiotic such as aminoglycoside, polymyxin class, mould rope etc. can play certain antibacterial action through the ages, its treatment window is narrower, easily causes nephrotoxicity and neurotoxicity etc., thereby has limited it by the heavy dose of application of vein.It is but very little on the impact of the drug level in blood that local atomization sucks antibacterials, so not only can reduce the dosage of systemic administration, and avoid the toxic and side effects of medicine, therefore encourages the auxiliary treatment of Inhalation in Treating as whole body therapeutic.Air flue provides a direct route of administration, high-efficiency atomizer makes antibacterials can pass through the direct targeted of air flue in lung, this medication can make in expectorant and lung tissue antimicrobial drug concentration higher than the several times of intravenously administrable, and far away higher than the minimum inhibitory concentration of pneumonia due to the treatment common bacteria.
It is the key of Successful treatment pneumonia that enough drug level and enough medicines are held time, but the pharmaceutical aerosol that the atomising device that does not still have the present listing of proof provides can effectively arrive the small airway of lung, can not determine whether atomization makes enough sustained drugs be deposited on the pulmonary infection kitchen range, and the atomization suction is subject to patient respiration fitness and patient dependence impact, can not guarantee that enough active drugs arrive the pathological changes part, this just makes being widely used of antibacterials of atomization suction be restricted.Therefore, at present in the urgent need to a kind of, can guarantee to suck antibacterials and can more effectively make enough antibacterials arrive the small airway of lung and the nebulization equipment of pulmonary infection focus, simultaneously, this device also can offer intestinal, the tracts such as urogenital tract carry out topical, better clinical service work.
Summary of the invention
In order to overcome above shortcomings on prior art, it is a kind of efficient that this utility model provides, accurately visual doser in local tract.
this utility model adopts following technical scheme to realize above-mentioned purpose: a kind of visual cavity/canal drug administration device comprises the topical nebulizer, visual device and the transparent tube body that adopts medical macromolecular materials to make, in body, axially be provided with topical passage and observation chamber, described topical nebulizer connects the connector that is arranged on the body rear end, by connector, medicine is delivered to the topical passage, in described observation chamber, be provided with optical fiber, optical fiber leads to body by observation chamber and forms exit outward, exit connects the signal input part of visual device, the observation chamber termination of described body front end is transparent sealing, termination at the topical passage is provided with cribriporal.
This utility model apparatus is because the advantage that has adopted said structure to have is: owing to having visuality, avoided the blindness in the atomization suction process, can make the atomization inhalation pipe front end arrive the lung small airway and exactly the inflammation of pulmonary be located, increase inflammation local antibacterial medicine administration concentration and hold time, also can reach intestinal, administration is carried out in the urogenital tract part, realize that high efficiency hangs down the toxic and side effects antibacterial therapy, and this is simple to operate without specification requirement.Add the turning traction steel wire, be convenient to the body that enters the positions such as lung small airway, intestinal, urogenital tract is controlled, also be convenient to the duct wall that this doser can more clearly be observed lung small airway, intestinal, urogenital tract.
The accompanying drawing explanation
This utility model apparatus can further illustrate by the indefiniteness embodiment that accompanying drawing provides.
Fig. 1 is structural representation of the present utility model;
Fig. 2 structural representation that to be this utility model be connected with nebulizer with visual device;
Fig. 3 is the structural representation that this utility model body is seen to the back-end from front end;
In figure: the 1-body; 2-optical fiber; The 3-through hole; The 4-connector; 5-topical nebulizer; The 6-visual device; 7-topical passage; The 8-observation chamber; The 9-cribriporal; The 10-traction steel wire; The outer retainer ring of 11-steel wire; The 12-steel wire pulls handle.
The specific embodiment
Below in conjunction with drawings and Examples, this utility model apparatus is described further.
As shown in Figure 1 and Figure 2, visual cavity/canal drug administration device, comprise topical nebulizer 5, visual device 6 and the transparent tube body 1 that adopts medical macromolecular materials to make, interior topical passage 7 and the observation chamber 8 of axially being provided with of body 1, described topical nebulizer 5 connects the connector 4 that is arranged on body 1 rear end, by connector 4, medicine is delivered to topical passage 7, in described observation chamber 8, be provided with optical fiber 2, optical fiber 2 leads to the outer formation exit of body 1 by observation chamber 8, and exit connects the signal input part of visual device 6.As shown in Figure 3, observation chamber 8 terminations of described body 1 front end are transparent sealings, in the termination of topical passage 7, are provided with cribriporal 9.
The front end of described body 1 is a head, and namely front end is the circular arc head.Described topical passage 7 sidewalls are provided with through hole 3 or cribriporal.
Inwall or the outer wall of being close to described body 1 are provided with the traction steel wire 10 of being convenient to body 1 front end turning.Traction steel wire 10 can be at the inboard wall of tube body of topical passage 7 or the inboard wall of tube body of observation chamber 8, the inboard wall of tube body in preferred view chamber 8.Traction steel wire 10 1 ends are connected with the outer retainer ring 11 of steel wire, and the other end pulls handle 12 to be connected with the steel wire that is arranged on body 1 rear end.On the outer wall of body 1 front end, be provided with groove, the outer retainer ring 11 of steel wire is fixed in described groove, makes retainer ring 11 and body 1 be in same plane.During operation, the push-and-pull steel wire pulls handle 12 that body 1 front end is turned.
Described visual device adopts superminiature imaging fiber system in " visual Catheter for sputum aspirating " system (application number is 200720188729.1,201010297841.5).The accurate branchofiberoscope XZ3 in Shanghai for example.
Operation principle of the present utility model: the front end of topical body 1 is inserted to air flue from mouth, nostril or tracheal intubation, the tail end of topical passage is connected with nebulizer 5; The front end of topical passage is deep into to inflammation under the guiding of visual device 6 and invades the lung peripheral airway of profit or look for the pulmonary infection focus, then open nebulizer and carry out the antibacterials topical.In like manner can be for intestinal and urogenital tract.The front end of topical body 1 is inserted to intestinal or inserts urethra from urethral orifice from anus, the tail end of topical passage is connected with nebulizer 5; Under the guiding of visual device 6, the front end of topical passage is inserted into to diseased region, then opens nebulizer and carry out the antibacterials topical.
Claims (7)
1. visual cavity/canal drug administration device, comprise topical nebulizer (5), visual device (6) and the transparent tube body (1) that adopts medical macromolecular materials to make, in body (1), axially be provided with topical passage (7) and observation chamber (8), it is characterized in that: described topical nebulizer (5) connects the connector (4) that is arranged on body (1) rear end, by connector (4), medicine is delivered to topical passage (7), in described observation chamber (8), be provided with optical fiber (2), optical fiber (2) leads to the outer exit that forms of body (1) by observation chamber (8), exit connects the signal input part of visual device (6), observation chamber (8) termination of described body (1) front end is transparent sealing, in the termination of topical passage (7), be provided with cribriporal (9).
2. visual cavity/canal drug administration device according to claim 1, it is characterized in that: the front end of described body (1) is a head.
3. visual cavity/canal drug administration device according to claim 2, it is characterized in that: described topical passage (7) sidewall is provided with through hole (3) or cribriporal.
4. according to claim 1 and 2 or 3 described visual cavity/canal drug administration devices is characterized in that: be close to the inwall of described body (1) or outer wall and be provided with and be convenient to the traction steel wire (10) that body (1) front end is turned.
5. visual cavity/canal drug administration device according to claim 4, it is characterized in that: described traction steel wire (10) one ends are connected with the outer retainer ring (11) of steel wire, the other end pulls handle (12) to be connected with the steel wire that is arranged on body (1) rear end, pulls handle that the body front end is turned.
6. visual cavity/canal drug administration device according to claim 5, is characterized in that: on the outer wall of body (1) front end, be provided with groove.
7. visual cavity/canal drug administration device according to claim 6, it is characterized in that: the outer retainer ring (11) of described steel wire is fixed in described groove.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013203632466U CN203291375U (en) | 2013-06-24 | 2013-06-24 | Visualized tract drug delivery device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013203632466U CN203291375U (en) | 2013-06-24 | 2013-06-24 | Visualized tract drug delivery device |
Publications (1)
Publication Number | Publication Date |
---|---|
CN203291375U true CN203291375U (en) | 2013-11-20 |
Family
ID=49567424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013203632466U Withdrawn - After Issue CN203291375U (en) | 2013-06-24 | 2013-06-24 | Visualized tract drug delivery device |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN203291375U (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103285504A (en) * | 2013-06-24 | 2013-09-11 | 重庆医科大学 | Visualization cavity dosing device |
CN106236007A (en) * | 2016-09-21 | 2016-12-21 | 柳州市工人医院 | A kind of anorectal inspection and doser |
-
2013
- 2013-06-24 CN CN2013203632466U patent/CN203291375U/en not_active Withdrawn - After Issue
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103285504A (en) * | 2013-06-24 | 2013-09-11 | 重庆医科大学 | Visualization cavity dosing device |
CN103285504B (en) * | 2013-06-24 | 2015-02-25 | 重庆医科大学 | Visualization cavity dosing device |
CN106236007A (en) * | 2016-09-21 | 2016-12-21 | 柳州市工人医院 | A kind of anorectal inspection and doser |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8245708B2 (en) | Methods, devices and formulations for targeted endobronchial therapy | |
US8261747B2 (en) | Methods, devices and formulations for targeted endobronchial therapy | |
AU2009233671B2 (en) | Methods, devices and formulations for targeted endobronchial therapy | |
CN206045127U (en) | A kind of dosing of pulsed dual pathways and Endotracheal tube | |
US20140014103A1 (en) | Methods, Devices and Formulations for Targeted Endobronchial Therapy | |
CN211068565U (en) | Tracheotomy sleeve capable of slowly releasing medicine | |
CN203291375U (en) | Visualized tract drug delivery device | |
US20130310734A1 (en) | Catheter for photodynamic therapy | |
CN103285504B (en) | Visualization cavity dosing device | |
CN203029815U (en) | Reagent feeder for respiration medicine | |
CN203816030U (en) | Ventilator atomizer | |
CN203315473U (en) | Atomizer for patient suffering from tracheotomy | |
CN201101810Y (en) | Disposal surface anesthesia atomizing tube for respiratory passage | |
CN204951931U (en) | Sprayer for ENT | |
CN111420193A (en) | Breathe medical internal medicine nursing multipurpose plant of dosing | |
CN215838959U (en) | Disposable multifunctional laryngoscope lens | |
CN201524332U (en) | Bi-directionally usable medication inhaler | |
CN219983627U (en) | Throat mist device for preventing and treating throat edema | |
CN203280892U (en) | Spraying dosing device via endotracheal tube | |
CN203355061U (en) | Multifunctional pneumatic atomization drug delivery device | |
CN219517430U (en) | Device of accurate nose district injection | |
CN220193795U (en) | Administration tube for endoscope | |
CN202161607U (en) | Multi-cavity fluid director with sputum suction, oxygen inhalation and atomization functions | |
CN2812984Y (en) | Medical atomizer multifunction joint | |
CN202052175U (en) | Remaining oxygen inhalation and sputum suction atomization tube |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
AV01 | Patent right actively abandoned |
Granted publication date: 20131120 Effective date of abandoning: 20150225 |
|
RGAV | Abandon patent right to avoid regrant |